NOXAFIL 40 mg/ml, oral suspension bottle, 105 ml
Active ingredients: Posaconazole
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 105 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NOXAFIL 40 mg/mL, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 105 ml avec fermeture de sécurité enfant avec cuillère-mesure polystyrène
- Marketing authorisation holder
- MERCK SHARP & DOHME (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62076503CIP73702398CIP133400937023986Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POSACONAZOLEsuspension | 40 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.